Treating progressive multifocal leukoencephalopathy with interleukin 7 and vaccination with JC virus capsid protein VP1

Standard

Treating progressive multifocal leukoencephalopathy with interleukin 7 and vaccination with JC virus capsid protein VP1. / Sospedra, Mireia; Schippling, Sven; Yousef, Sara; Jelcic, Ilijas; Bofill-Mas, Silvia; Planas, Raquel; Stellmann, Jan-Patrick; Demina, Viktoria; Cinque, Paola; Garcea, Robert; Croughs, Therese; Girones, Rosina; Martin, Roland.

In: CLIN INFECT DIS, Vol. 59, No. 11, 01.12.2014, p. 1588-92.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Sospedra, M, Schippling, S, Yousef, S, Jelcic, I, Bofill-Mas, S, Planas, R, Stellmann, J-P, Demina, V, Cinque, P, Garcea, R, Croughs, T, Girones, R & Martin, R 2014, 'Treating progressive multifocal leukoencephalopathy with interleukin 7 and vaccination with JC virus capsid protein VP1', CLIN INFECT DIS, vol. 59, no. 11, pp. 1588-92. https://doi.org/10.1093/cid/ciu682

APA

Sospedra, M., Schippling, S., Yousef, S., Jelcic, I., Bofill-Mas, S., Planas, R., Stellmann, J-P., Demina, V., Cinque, P., Garcea, R., Croughs, T., Girones, R., & Martin, R. (2014). Treating progressive multifocal leukoencephalopathy with interleukin 7 and vaccination with JC virus capsid protein VP1. CLIN INFECT DIS, 59(11), 1588-92. https://doi.org/10.1093/cid/ciu682

Vancouver

Bibtex

@article{4a323600ae85401a8361f7095b1b2941,
title = "Treating progressive multifocal leukoencephalopathy with interleukin 7 and vaccination with JC virus capsid protein VP1",
abstract = "Progressive multifocal leukoencephalopathy is a currently untreatable infection of the brain. Here, we demonstrate in 2 patients that treatment with interleukin 7, JC polyomavirus (JCV) capsid protein VP1, and a Toll-like receptor 7 agonist used as adjuvant, was well tolerated, and showed a very favorable safety profile and unexpected efficacy that warrant further investigation.",
author = "Mireia Sospedra and Sven Schippling and Sara Yousef and Ilijas Jelcic and Silvia Bofill-Mas and Raquel Planas and Jan-Patrick Stellmann and Viktoria Demina and Paola Cinque and Robert Garcea and Therese Croughs and Rosina Girones and Roland Martin",
note = "{\textcopyright} The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.",
year = "2014",
month = dec,
day = "1",
doi = "10.1093/cid/ciu682",
language = "English",
volume = "59",
pages = "1588--92",
journal = "CLIN INFECT DIS",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "11",

}

RIS

TY - JOUR

T1 - Treating progressive multifocal leukoencephalopathy with interleukin 7 and vaccination with JC virus capsid protein VP1

AU - Sospedra, Mireia

AU - Schippling, Sven

AU - Yousef, Sara

AU - Jelcic, Ilijas

AU - Bofill-Mas, Silvia

AU - Planas, Raquel

AU - Stellmann, Jan-Patrick

AU - Demina, Viktoria

AU - Cinque, Paola

AU - Garcea, Robert

AU - Croughs, Therese

AU - Girones, Rosina

AU - Martin, Roland

N1 - © The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

PY - 2014/12/1

Y1 - 2014/12/1

N2 - Progressive multifocal leukoencephalopathy is a currently untreatable infection of the brain. Here, we demonstrate in 2 patients that treatment with interleukin 7, JC polyomavirus (JCV) capsid protein VP1, and a Toll-like receptor 7 agonist used as adjuvant, was well tolerated, and showed a very favorable safety profile and unexpected efficacy that warrant further investigation.

AB - Progressive multifocal leukoencephalopathy is a currently untreatable infection of the brain. Here, we demonstrate in 2 patients that treatment with interleukin 7, JC polyomavirus (JCV) capsid protein VP1, and a Toll-like receptor 7 agonist used as adjuvant, was well tolerated, and showed a very favorable safety profile and unexpected efficacy that warrant further investigation.

U2 - 10.1093/cid/ciu682

DO - 10.1093/cid/ciu682

M3 - SCORING: Journal article

C2 - 25214510

VL - 59

SP - 1588

EP - 1592

JO - CLIN INFECT DIS

JF - CLIN INFECT DIS

SN - 1058-4838

IS - 11

ER -